Methylcobalamin

# Methylcobalamin ## Overview - **Classification**: Vitamin B12 analog, water-soluble vitamin - **Mechanism**: Essential coenzyme for DNA synthesis, nerve cell function, and red blood cell formation. Supports methionine synthase and methylmalonyl-CoA mutase pathways. ## Primary Indications 1. **Vitamin B12 Deficiency**: Due to malabsorption (e.g., pernicious anemia, Crohn's disease), gastrectomy, dietary insufficiency (vegans), or certain medications. 2. **Methylmalonic Acidemia/Homocystinuria**: Inborn errors of metabolism sensitive to B12. 3. **Peripheral Neuropathy**: Used for symptomatic relief, particularly in diabetic neuropathy (off-label). ## Adult Dosing ### Standard Dosing **Vitamin B12 Deficiency (e.g., Pernicious Anemia, Malabsorption)** - **Dose**: **1000 mcg** - **Frequency**: Intramuscularly (IM) daily for 7-14 days, then weekly for 4-8 weeks, then monthly for life. - **Route**: IM injection (preferred for severe deficiency/malabsorption). - **Alternative (Oral/Sublingual)**: **1000-2000 mcg** daily. - **Duration**: Often lifelong for malabsorption causes. **Peripheral Neuropathy (Off-label)** - **Dose**: **500 mcg** to **1500 mcg** - **Frequency**: IM 1-3 times per week, or oral/sublingual **1500 mcg** daily. - **Route**: IM or Oral/Sublingual. ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment generally needed. Methylcobalamin is water-soluble. - **Hepatic Impairment**: No specific dose adjustment generally needed. - **Elderly Patients**: No specific dose adjustments. Monitor for B12 deficiency as prevalence increases with age. ## Pediatric Dosing ### Neonates (0-28 days) **Vitamin B12 Deficiency (e.g., maternal deficiency, inborn errors)** - **Dose**: **250 mcg** to **1000 mcg** - **Frequency**: IM daily for 7 days, then weekly for 4 weeks. - **Maximum**: **1000 mcg** IM daily. - **Special Notes**: Consider IM route for rapid correction. May be followed by monthly maintenance. ### Infants (1-12 months) **Vitamin B12 Deficiency** - **Dose**: **250 mcg** to **1000 mcg** - **Frequency**: IM daily for 7 days, then weekly for 4 weeks. - **Maximum**: **1000 mcg** IM daily. - **Special Notes**: Oral/sublingual preparations (e.g., **1000 mcg** daily) can be considered for less severe cases or maintenance. ### Children (1-12 years) **Vitamin B12 Deficiency** - **Dose**: **500 mcg** to **1000 mcg** - **Frequency**: IM daily for 7-14 days, then weekly for 4-8 weeks, then monthly. - **Maximum**: **1000 mcg** IM daily. - **Special Notes**: Oral/sublingual preparations (e.g., **1000-2000 mcg** daily) are often effective for maintenance. ### Adolescents (13-18 years) **Vitamin B12 Deficiency** - **Dose**: Follow adult dosing guidelines. **1000 mcg** - **Frequency**: IM daily for 7-14 days, then weekly for 4-8 weeks, then monthly for life. - **Maximum**: **1000 mcg** IM daily or **2000 mcg** oral/sublingual daily. ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to cobalt or vitamin B12. - **Absolute**: Leber's disease or tobacco amblyopia (use caution, may cause optic nerve atrophy). ### Common Adverse Effects - **Very Common (>10%)**: Pain or redness at IM injection site. - **Common (1-10%)**: Mild diarrhea, mild itching, rash, headache. - **Serious but Rare**: Anaphylaxis, peripheral vascular thrombosis, pulmonary edema, congestive heart failure. ### Key Drug Interactions - **Metformin**: Can decrease vitamin B12 absorption; monitor B12 levels in patients on long-term metformin. - **Proton Pump Inhibitors (PPIs)/H2 Receptor Blockers**: Can decrease B12 absorption; monitor B12 levels, especially with long-term use. - **Chloramphenicol**: Can antagonize the hematopoietic response to B12 in some patients; monitor CBC closely. - **Colchicine**: Can decrease B12 absorption; monitor B12 levels. - **Chronic Alcohol Intake**: Can decrease B12 absorption; monitor B12 levels. ## Monitoring & Follow-up - **Before Treatment**: Baseline serum B12, folate, complete blood count (CBC) with differential, reticulocyte count, methylmalonic acid (MMA), homocysteine. - **During Treatment**: - **Initial**: CBC, reticulocyte count 5-7 days after initiating therapy, then monthly for 3-6 months. - **Ongoing**: Serum B12 levels annually or as clinically indicated. - **Clinical Signs**: Monitor for resolution of neurological symptoms (e.g., paresthesias, gait disturbances) and improvement in fatigue. ## Clinical Pearls - 💡 **Administration**: Oral or sublingual methylcobalamin is effective for most deficiencies, except in severe malabsorption (e.g., gastric bypass, severe pernicious anemia) where IM is preferred. - 💡 **Lifelong Therapy**: For conditions like pernicious anemia or chronic malabsorption, B12 therapy is typically lifelong. - 💡 **Folate Deficiency**: Rule out or treat concurrent folate deficiency, as B12 administration can mask hematologic symptoms of folate deficiency while neurologic damage progresses. - 💡 **Patient Counseling**: Explain the importance of consistent therapy and monitoring. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.